Area of research
Cancer Research · Gender Studies
Research interest
Research interests include Breast Cancer Treatment Studies, Diversity and Career in Medicine, Advances in Oncology and Radiotherapy, and Economic and Financial Impacts of Cancer.
Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy
NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
The Lancet Breast Cancer Commission
Abstract GS02-07: Loco-Regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node-negative After Neoadjuvant Chemotherapy: Primary Outcomes of NRG Oncology/NSABP B-51/RTOG 1304
Burnout Among Mid-Career Academic Medical Faculty
A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO): NRG-BR008.
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
Patient-reported Quality of Life After Breast-conserving Surgery With Radiotherapy Versus Mastectomy and Reconstruction
Inflammatory breast cancer defined: proposed common diagnostic criteria to guide treatment and research
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.
Readability of Patient Education Materials From High-Impact Medical Journals: A 20-Year Analysis
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021
Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial
Ethical Challenges Arising in the COVID-19 Pandemic: An Overview from the Association of Bioethics Program Directors (ABPD) Task Force
Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic
Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer
Childbearing Decisions in Residency: A Multicenter Survey of Female Residents
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives
Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer
Performance Status Restriction in Phase III Cancer Clinical Trials
Socioeconomic Factors Associated With Burnout Among Oncology Trainees
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants
Comparison of Population-Based Observational Studies With Randomized Trials in Oncology
Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients
Assessment of Use, Specificity, and Readability of Written Clinical Informed Consent Forms for Patients With Cancer Undergoing Radiotherapy
Readability of Patient Education Materials in Radiation Oncology—Are We Improving?
Sex-Based Disparities Among Cancer Clinical Trial Participants
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline